AstraZeneca’s patent on asthma drug invalidated by U.S. court – Business Insider


Business Insider

AstraZeneca's patent on asthma drug invalidated by U.S. court
Business Insider
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
AstraZeneca plc (ADR) Patent On Asthma Drug Declared Invalid By US CourtBidness ETC
AstraZeneca loses its US patent rights for asthma drug Pulmicort RespulesCITY A.M.

all 37 news articles »

View full post on asthma – Google News

AstraZeneca’s patent on asthma drug invalidated by US court – Reuters


Reuters

AstraZeneca's patent on asthma drug invalidated by US court
Reuters
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
Actavis launches Pulmicort Respules generic on AZ legal lossPharmaTimes

all 7 news articles »

View full post on asthma – Google News

AstraZeneca’s patent on asthma drug invalidated by US court – Yahoo News


euronews

AstraZeneca's patent on asthma drug invalidated by US court
Yahoo News
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
Actavis launches Pulmicort Respules generic on AZ legal lossPharmaTimes

all 2 news articles »

View full post on asthma – Google News